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ㅋ
Pneumatic dilation (PD) is an effective treatment for achalasia cardia. Outcome of PD, however, varies among different studies. 
Recently, some groups started considering laparoscopic myotomy to be competitive to PD in treatment of achalasia considering 
dreaded complication like perforation following the latter therapeutic approach. Therefore, there is need to predict outcome 
of PD for achalasia, so that appropriate therapy, both for treatment naïve and for treatment failed patients can be chosen. 
Apart from age and gender, 2 investigations, namely post-PD manometry and timed barium esophagogram are most often 
used to predict outcome after PD. Even though there are studies available in the literature with regard to these modalities to 
predict outcome of PD, these are quite few in number, including small number of patients, primarily because of rarity of the 
disease. In this article, we review the literature predicting outcome of PD for achalasia. 
(J Neurogastroenterol Motil 2011;17:9-13)
Key Words
Achalasia; Dysphagia; Esophageal dysmotility; Manometry
Received: June 16, 2010 Revised: July 5, 2010 Accepted: July 13, 2010
CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. 
org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work 
is properly cited.
*Correspondence: Uday C Ghoshal, MD, DNB, DM, FACG
Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, 
India
Tel: +91-962-884-2456, Fax: +91-522-266-8017 (or 8078), E-mail: Udayghoshal@gmail.com
Financial support: None.
Conflicts of interest: None.
Introduction
Achalasia cardia is a rare primary esophageal motor disorder, 
which is diagnosed on the basis of esophageal manometry.
1 
Typical manometry findings in achalasia are aperistalsis of esoph-
ageal body and incomplete relaxation of lower esophageal sphinc-
ter (LES).
2 Based on average esophageal body amplitude, acha-
lasia is classified into classic (≤ 40 mmHg) and vigorous types 
(> 40 mmHg).
3 Vigorous achalasia is considered as the early 
stage in the natural history of the disease.
4,5 Treatment of acha-
lasia is usually palliative in nature.
6 There are 3 main modes of 
therapy: pneumatic dilation (PD), botulinum toxin injection 
(both through endoscopic means) and surgery (Heller’s car-
diomyotomy). Endoscopic PD and surgery are effective in pro-
viding long-term remission.
7
Pneumatic Dilation
PD is the most popular non-surgical treatment of achalasia. 
Moreover, it is cost-effective compared to botulinum toxin in-
jection and surgery.
8-10 PD can be performed with different dila-Uday C Ghoshal and Murali Rangan
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Table 1. Possible Predictors of Outcome Following Pneumatic 
Dilation of Achalasia Cardia
Demographic and clinical parameters
Age
Gender
Specific symptom(s)
Duration and type of achalasia
Manometry
LESP (baseline and post-PD)
Amplitude of contractions
Timed barium esophagogram
Height and width of barium column
LESP, lower esophageal sphincter pressure; PD, pneumatic diation.
Table 2. Summary of Factors Useful to Predict Outcome of 
Pneumatic Dilation of Achalasia Cardia as Found in Different 
Studies
Author Patient  Study 
Predictor(s)
and Year number type
Ponce, 1996 157 P Age, sex, esophageal body
  diameter and basal LESP
Eckardt, 1992   54 P Age, balloon diameter and
  post-PD LESP
Vaezi, 2004   75 R Age, sex and timed barium 
  esophagogram
Mehta, 2005   52 R Age
Ghoshal, 2004 126 R Sex and post-PD LESP
Chuah, 2009   32 P Age
P, prospective study; R, retrospective study; LESP, lower esophageal sphincter 
pressure; PD, pneumatic dilation.
Table 3. Summary of Studies Predicting Outcome of Pneumatic 
Dilation of Achalasia Cardia
Predictors Outcome
Old age (> 45 yr) Favorable
Male gender Poor
Large balloon size Favorable
Post-PD LESP < 10 mmHg Favorable
Post-PD LESP reduction by > 50% Favorable
Complete emptying in TBE Favorable
PD, pneumatic dilation; LESP, lower esophageal sphincter pressure; TBE, 
timed barium esophagogram.
tors of variable balloon compliances. Low compliance poly-
ethylene pneumatic dilator (Rigiflex dilator) is most widely used 
because of its theoretical advantages over the high compliance 
balloon dilator.
11 Most feared complication of PD is esophageal 
perforation. Perforation rate varies from less than 1% to 3% in 
various studies.
12-16 Furthermore, PD is effective in 64%-87% 
patients.
12 Also, a proportion of initial responders experience re-
currence during long-term follow-up. Therefore, it is important 
to predict which patient is less likely to respond or develop re-
currence following an initial response for the following reasons; 
(1) to devise treatment strategy in a given patient, (2) to prognos-
ticate, (3) to plan early re-intervention, if required, and (4) to help 
understand pathophysiology of the disease. Table 1 shows the 
likely predictors of outcome following PD for achalasia cardia. 
The studies published in literature addressing the issue on 
predictors of outcome of PD (Tables 1-3) differ in type of dilator 
used, symptom scores used to assess the outcomes (response and 
recurrence), treatment protocol for management of recurrence 
and investigations used to predict outcomes etc. In spite of such 
heterogeneity between the studies, these do provide valuable in-
formation, which can guide physician in planning treatment stra-
tegy.
The first large prospective study was done by Ponce et al
17 in 
which 157 patients with achalasia underwent PD with Witzel 
dilator. Patients who had post-PD lower esophageal sphincter 
pressure (LESP) < 10 mmHg had a better outcome than others. 
Using Bayes’ theorem, a predictive model was constructed in-
cluding 5 most discriminating values: age < 20 years, male sex, 
diameter of esophageal body < 3 cm, basal pressure of esoph-
ageal body > 15 mmHg and LESP > 30 mmHg. Jackknife 
method was used to validate the model. The limitation of this 
study was lack of use of conventional statistics including multi-
variate analysis. Furthermore, Witzel dilator has high compliance 
balloon that is no longer in use.
Mehta et al
18 reported a retrospective study on 52 patients us-
ing Rigiflex balloon in whom 81% responded to PD. On uni-
variate analysis, non-responders were younger in age (< 40 
years), had high baseline LESP (> 50 mmHg) and reduced 
mid-esophageal contractions (amplitude < 30 mmHg). There 
was no significant difference in response rates with respect to 
gender. On multivariate analysis, only young age was associated 
with poor response, though patients with high baseline LES pres-
sure showed a trend towards poor response. Esophageal man-
ometry was not repeated after PD in this study.
From our center, we reported a retrospective study on 126 
patients who had undergone PD for achalasia.
12 On univariate 
analysis, regurgitation, chest pain, pulmonary symptoms and 
male gender were associated with non-response. Post-PD reduc-
t i o n  i n  L E S P  b y  m o r e  t h a n  5 0 %  w a s  a s s o c i a t e d  w i t h  g o o d  
response. On multivariate analysis, male gender was the only fac-Predictors of Outcome of PD in Achalasia
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tor, which was associated with worse outcome. This is the largest 
study in which a low compliance dilator (Rigiflex) was used. But, 
post-PD manometry was not done in all the patients in this study.
Eckardt et al
19,20 reported outcome of management of 54 pa-
tients with achalasia cardia with PD. Symptom score and LESP 
were assessed at baseline and at 4 weeks after PD. Follow-up as-
sessment of symptom score was done at 2 yearly intervals for a 
median of 13.8 years. Of 35 patients who had relapse, 32 relapsed 
within 5 years. Long-term outcome was significantly better in pa-
tients with age older than 40 years and post-PD LESP < 10 
mmHg. Even though this study was prospective with long-term 
follow-up, the authors have used Brownie Mchardy dilator (high 
compliance balloon) which is not being used now-a-days.
Farhoomand et al
21 reported a retrospective analysis of 75 pa-
tients who underwent PD with Rigiflex dilator. Symptom scoring 
and timed barium esophagogram were done in all the patients at 
baseline and at 1 month after PD. Among the patients who had 
undergone PD with 30 mm balloon, retreatment was required 
less often compared to the patients who had undergone PD with 
35 and 40 mm balloon. Especially, early failure rate (within 3 
months) was high among those who had undergone PD with 30 
mm balloon compared to those in whom larger balloon diameter 
was used. Also, 22 of 25 patients who had early failure were men. 
Multivariate Cox proportional hazards model revealed that 
younger men (< 45 years) required additional therapy more fre-
quently compared to older men and also the difference in re-
sponse rate between male and female became narrower as age 
advanced. Thus they concluded that failure was commoner 
among young men who had undergone PD with 30 mm balloon. 
Similar to their previous study in which complete barium empty-
ing in timed barium esophagogram was found to strongly corre-
late with symptomatic improvement, including long-term re-
mission, this study also showed that those who did not require 
re-treatment more often had complete barium emptying after 
PD.
22 Post-PD manometry was not done in this study. The au-
thors suggested that male patients with achalasia should be treat-
ed with 35 mm balloon for even the first session of PD as 30 mm 
balloon often failed in them and post-PD timed barium esoph-
agogram predicted long-term outcome after PD. A prospective 
study by Chuah et al
23 on 32 patients managed with Rigiflex dila-
tor also concluded that age more than 45 years was the only sig-
nificant factor predicting favorable outcome.
Even though, some studies evaluated duration of dysphagia 
and type of achalasia as possible parameters predicting outcome, 
they were not found important in predicting outcome even in uni-
variate analysis.
12,17-19 Post-PD manometry and timed barium 
esophagogram are the 2 most widely used investigations to pre-
dict the outcome after PD. Manometry studies have used various 
criteria to predict the outcome such as post-PD LESP < 10 
mmHg and reduction of LESP by more than 50% of baseline 
LESP.
Andersson et al
24 reported a prospective study, in which 51 
patients with achalasia were randomized into 2 treatment groups, 
namely PD and laparoscopic myotomy. Timed barium esophago-
gram was done at baseline and after treatment. The median fol-
low-up time after the post-treatment timed barium esophago-
gram was 18 months. They found a significant correlation be-
tween barium emptying at 1 minute and symptom scores at the 
end of follow-up period in both the groups. Patients with less 
than 50% improvement in this parameter after treatment had a 
40% risk of treatment failure on follow-up.
The recently introduced high resolution manometry displays 
spatiotemporal plots of esophageal body and LESPs.
25,26 It also 
helps us to understand the segmental functional anatomy of 
esophageal body and LES, which contributes to our under-
standing of various subsets of achalasia and possibly their differ-
ence in response to various modes of treatment. Till now, this at-
tractive research tool has not been studied for predicting the out-
come of PD in achalasia.
Why Is Pneumatic Dilation Less Effective 
  in Men?
Explanation for worse outcome of PD among men is un-
known. However, one may hypothesize that LES muscles might 
be stronger among men than women that might be responsible 
for worse outcome among them. LES tone might be more in 
younger men than in older men, thus further explaining less fa-
vorable outcome in young men. However, this needs to be stu-
died further.
Why Is Old Age a Favorable Predictor?
Apart from some of the above discussed studies, there are 
many other studies in literature which concluded old age as a pre-
dictor of favorable outcome.
27-30 Though, the exact reason for this 
is not known, there are various hypotheses to explain this finding.
Anatomically, LES has 2 components, namely clasp fibers 
encircling the gastroesophageal junction medially and gastric 
sling fibers present on left lateral side. In PD, only the clasp fi-Uday C Ghoshal and Murali Rangan
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bers are targeted. Hence, it is possible that gastric sling fibers,  
unaffected by PD, contribute to residual LES tone in these pa-
tients after PD. As discussed previously, this tone is likely to be 
higher in younger patients, thus explaining poor response in 
young patients.
31 Patients with long-standing symptoms often in-
terpret mild improvement in esophageal emptying as dramatic re-
lief from dysphagia.
32 Older patients perceive less pain compared 
to their younger counterparts when balloon is distended in 
esophagus.
33 Also, older patients are expected to have weaker 
LES muscles that might be easily torn during PD.
Clinical Implications
Young men having persistently high LESP and poor esoph-
ageal emptying after PD might be better treated by laparoscopic 
myotomy rather than persisting with repeated PDs. Similarly, old 
women after PD having low (or > 50% reduced) LESP and 
good esophageal emptying may be offered repeated PD in the 
unlikely event of recurrence. Thirty-five mm instead of 30 mm 
balloon should be tried for first PD, particularly in males.
Need for Future Research
A prospective study with large number of patients and 
long-term follow-up is needed. Both timed barium esophago-
gram and manometry, especially high resolution manometry 
should be done at baseline and post-PD, so that they can be com-
pared in their value in predicting outcome. Strong statistical 
methods will add to the strength of evidence.
Conclusion
PD is an effective alternative to surgery. The response to PD 
depends on age and gender of the patient and size of the balloon 
used for PD. The long-term response can be predicted with the 
help of post-PD manometry and timed barium esophagogram. 
Balloon size has to be chosen according to the gender. Further 
prospective studies with larger numbers are needed.
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